金币
UID3938
帖子
主题
积分3537
注册时间2011-10-16
最后登录1970-1-1
听众
性别保密
|
发表于 2016-6-30 07:39:21
|
显示全部楼层
3,在FDA的PAI批准前现场检查程序手册中,有如下描述:
Objective 3ata Integrity Audit 目标3,数据完整性审核
Audit the raw data, hardcopy or electronic, to authenticate the data submitted in the CMC section of the application. Verify that all relevant data (e.g., stability, biobatch data) were submitted in the CMC section such that CDER product reviewers can rely on the submitted data as complete and accurate.审核纸质或电子形式的原始数据,以确认CMC部分提交的申报数据,核实所有在CMC资料中提交的相关数据(例如,稳定性数据,生物批),以便CDER产品审评员能信任递交数据的完整性、准确性。
此文明确DI在于“complete”完整(完全)与“accurate”准确。
Thoroughly document unreliable data. 详细地记录不可信/靠的数据。
|
|